DeepMed Research

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects

Not Applicable

Completed

Conditions: Alcohol Dependence

Interventions: Drug: D-Cycloserine PO and Glycine IV
Drug: Placebo D-Cycloserine PO and placebo Glycine IV
Drug: Placebo D-Cycloserine PO and Glycine IV
Drug: D-Cycloserine PO and placebo Glycine IV

First Posted Date: 2008-03-13

Last Posted Date: 2016-12-16

Lead Sponsor: Yale University

Target Recruit Count: 57

Registration Number: NCT00635102

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Clinical Trial of Integrated Treatment for Pain and Opioid Dependence

Phase 1

Completed

Conditions: Opiate Dependence
Chronic Pain

Interventions: Behavioral: CBT
Drug: Buprenorphine
Other: Educational Counseling
Other: Physician Management

First Posted Date: 2008-03-13

Last Posted Date: 2021-08-02

Lead Sponsor: Yale University

Target Recruit Count: 90

Registration Number: NCT00634803

Locations: 🇺🇸
Methadone Research Unit, New Haven, Connecticut, United States

The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers

Not Applicable

Completed

Conditions: Smoking

Interventions: Drug: Placebo
Drug: Cycloserine

First Posted Date: 2008-03-11

Last Posted Date: 2012-04-11

Lead Sponsor: Yale University

Target Recruit Count: 20

Registration Number: NCT00633256

Locations: 🇺🇸
West Haven VA, West Haven, Connecticut, United States

Effective Treatment of Hepatitis C in Substance Users

Not Applicable

Completed

Conditions: Opiate Dependence
Hepatitis C

Interventions: Procedure: Modified Directly Observed Therapy (mDOT)
Procedure: Self-Administered Therapy (SAT)

First Posted Date: 2008-03-11

Last Posted Date: 2013-01-03

Lead Sponsor: Yale University

Target Recruit Count: 21

Registration Number: NCT00633243

Locations: 🇺🇸
South Central Rehabilitation Agency, New Haven, Connecticut, United States

Family History Study of Alcohol Consumption Using Memantine

Phase 2

Completed

Conditions: Alcohol Drinking

Interventions: Drug: Memantine
Drug: Placebo

First Posted Date: 2008-03-07

Last Posted Date: 2020-03-17

Lead Sponsor: Yale University

Target Recruit Count: 111

Registration Number: NCT00630955

Locations: 🇺🇸
CMHC, New Haven, Connecticut, United States

Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

Phase 4

Completed

Conditions: Pregnancy
HIV Infections
Sexually Transmitted Diseases

Interventions: Behavioral: Usual care
Behavioral: CenteringPregnancy Plus (CP+)

First Posted Date: 2008-03-05

Last Posted Date: 2020-04-03

Lead Sponsor: Yale University

Target Recruit Count: 1233

Registration Number: NCT00628771

Locations: 🇺🇸
Yale University School of PUblic Health, New Haven, Connecticut, United States
🇺🇸
Clinical Directors Network, New York, New York, United States
🇺🇸
Centering Healthcare Institute, Boston, Massachusetts, United States

Stress Reduction to Reduce Risk for Arrhythmia in ICD Patients (The RISTA Study)

Not Applicable

Completed

Conditions: Arrhythmias, Cardiac

Interventions: Behavioral: Stress reduction treatment (SRT) program

First Posted Date: 2008-03-03

Last Posted Date: 2018-01-17

Lead Sponsor: Yale University

Target Recruit Count: 314

Registration Number: NCT00627263

Locations: 🇺🇸
Yale University Medical School, New Haven, Connecticut, United States

Cannabinoid Receptor Function & Alcoholism

Phase 1

Completed

Conditions: Alcoholism

Interventions: Drug: Placebo
Drug: THC

First Posted Date: 2008-02-27

Last Posted Date: 2022-03-11

Lead Sponsor: Yale University

Target Recruit Count: 29

Registration Number: NCT00624715

Locations: 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States

Early Versus Delayed Routine HIV Testing in Connecticut Jails

Early Phase 1

Completed

Conditions: HIV Infections

Interventions: Other: routine HIV testing

First Posted Date: 2008-02-27

Last Posted Date: 2014-10-17

Lead Sponsor: Yale University

Target Recruit Count: 621

Registration Number: NCT00624247

Locations: 🇺🇸
New Haven Community Correctional Center, New Haven, Connecticut, United States
🇺🇸
York Correctional Institution, Niantic, Connecticut, United States

Rapamycin for Prevention of Chronic Graft-Versus-Host Disease

Phase 1

Terminated

Conditions: Graft Versus Host Disease

Interventions: Drug: Rapamycin
Drug: Tacrolimus

First Posted Date: 2008-02-25

Last Posted Date: 2017-02-03

Lead Sponsor: Yale University

Target Recruit Count: 2

Registration Number: NCT00623012

Locations: 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy